Endo Pharmaceuticals, Inc.
Recent News About Endo Pharmaceuticals, Inc.
-
Impax to pay $145M to settle Opana drug market manipulation claims from pharmacies, other direct purchasers
The lawsuit accused Impax Labs of agreeing with drugmaker Endo Pharmaceuticals to delay the entry of its Opana generic equivalent. The deal came quickly after a jury found in favor of Endo on the antitrust claims -
Miss. AG, with the help of outside attorneys, sues pharma companies over allegedly unapproved drugs
Attorney General Jim Hood filed six separate lawsuits against the defendant companies in Hinds County Chancery Court last month. The companies have since asked the lawsuits to be removed to federal court, arguing the attorney general’s complaints require the determination of issues of federal law. -
Drug makers want Cohen Milstein law firm off New Hampshire investigation
A group of five pharmaceutical companies being investigated by state Attorney General Joseph Foster for their marketing of prescription opioids have filed motions with a state court to have the plaintiffs law firm barred, along with the enforcement of subpoenas from Foster’s office. The companies argue the firm has too much of a financial stake in the investigation.